Trial Outcomes & Findings for Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit (NCT NCT02588573)

NCT ID: NCT02588573

Last Updated: 2019-02-08

Results Overview

Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

103 participants

Primary outcome timeframe

8 hours

Results posted on

2019-02-08

Participant Flow

Of the 103 enrolled, 13 participants were not eligible due to screen failure. This reporting group includes 90 participants (180 eyes) belonging to 2 groups of 45 habitual wearers of either etafilcon A lens or frequent replacement lenses (FREQ). All participants were randomized to wear etafilcon A in one eye and somofilcon A in the fellow eye.

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
Habitual Etafilcon A Wearers
Habitual wearers of etafilcon A were randomized to wear etafilcon A lens in one eye and somofilcon A lens in the other eye for 8 hours during the contralateral study
Habitual FREQ Wearers
Habitual wearers of other frequent replacement lenses (FREQ) were randomized to wear etafilcon A lens in one eye and somofilcon A lens in the other eye for 8 hours during the contralateral study.
Overall Study
STARTED
45 90
45 90
Overall Study
Randomized Eye Etafilcon A
45 45
45 45
Overall Study
Randomized Eye Somofilcon A
45 45
45 45
Overall Study
COMPLETED
45 90
45 90
Overall Study
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Habitual Etafilcon A Wearers Wearing Etafilcon A/Somofilcon A
n=45 Participants
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design for 8 hours during the study.
Habitual FREQ Wearers Wearing Etafilcon A/Somofilcon A
n=45 Participants
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design for 8 hours during the study.
Total
n=90 Participants
Total of all reporting groups
Age, Continuous
25 years
n=5 Participants
25 years
n=7 Participants
25 years
n=5 Participants
Sex: Female, Male
Female
35 Participants
n=5 Participants
37 Participants
n=7 Participants
72 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
8 Participants
n=7 Participants
18 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 8 hours

Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.

Outcome measures

Outcome measures
Measure
Habitual Etafilcon A Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual Etafilcon A Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Habitual FREQ Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual FREQ Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Comfort
83 units on a scale
Standard Deviation 17
77 units on a scale
Standard Deviation 22
83 units on a scale
Standard Deviation 14
83 units on a scale
Standard Deviation 16

PRIMARY outcome

Timeframe: Baseline and 8 hours

Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens

Outcome measures

Outcome measures
Measure
Habitual Etafilcon A Wearers Randomized to Etafilcon A
n=45 Participants
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual Etafilcon A Wearers Randomized to Somofilcon A
n=45 Participants
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Habitual FREQ Wearers Randomized to Etafilcon A
n=45 Participants
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual FREQ Wearers Randomized to Somofilcon A
n=45 Participants
Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Comfort Preference
Strongly Prefer Etafilcon A Lens
7 participants
3 participants
13 participants
2 participants
Comfort Preference
Slightly Prefer Etafilcon A Lens
14 participants
10 participants
11 participants
16 participants
Comfort Preference
No Preference
12 participants
19 participants
5 participants
10 participants
Comfort Preference
Slightly Prefer Somofilcon A Lens
10 participants
11 participants
9 participants
8 participants
Comfort Preference
Strongly Prefer Somofilcon A Lens
2 participants
2 participants
7 participants
9 participants

PRIMARY outcome

Timeframe: Baseline and 8 hours

Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.

Outcome measures

Outcome measures
Measure
Habitual Etafilcon A Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual Etafilcon A Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Habitual FREQ Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual FREQ Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Bulbar Hyperemia
Baseline
1.3 units on a scale
Standard Deviation 0.4
1.3 units on a scale
Standard Deviation 0.4
1.2 units on a scale
Standard Deviation 0.4
1.2 units on a scale
Standard Deviation 0.4
Bulbar Hyperemia
8 hours
1.3 units on a scale
Standard Deviation 0.4
1.3 units on a scale
Standard Deviation 0.4
1.2 units on a scale
Standard Deviation 0.4
1.2 units on a scale
Standard Deviation 0.4

PRIMARY outcome

Timeframe: Baseline and 8 hours

Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.

Outcome measures

Outcome measures
Measure
Habitual Etafilcon A Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual Etafilcon A Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Habitual FREQ Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual FREQ Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Limbal Hyperemia
Baseline
1.2 units on a scale
Standard Deviation 0.5
1.2 units on a scale
Standard Deviation 0.5
1.0 units on a scale
Standard Deviation 0.4
1.0 units on a scale
Standard Deviation 0.4
Limbal Hyperemia
8 hours
1.2 units on a scale
Standard Deviation 0.4
1.3 units on a scale
Standard Deviation 0.4
1.4 units on a scale
Standard Deviation 0.5
1.3 units on a scale
Standard Deviation 0.4

PRIMARY outcome

Timeframe: 8 hours

Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas: N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central

Outcome measures

Outcome measures
Measure
Habitual Etafilcon A Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual Etafilcon A Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Habitual FREQ Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual FREQ Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Conjunctival Staining
Nasal
1.0 units on a scale
Standard Deviation 0.8
1.1 units on a scale
Standard Deviation 1.0
1.1 units on a scale
Standard Deviation 1.0
1.4 units on a scale
Standard Deviation 1.0
Conjunctival Staining
Temporal
0.4 units on a scale
Standard Deviation 0.5
1.1 units on a scale
Standard Deviation 0.9
0.6 units on a scale
Standard Deviation 0.6
1.4 units on a scale
Standard Deviation 1.0
Conjunctival Staining
Superior
0.3 units on a scale
Standard Deviation 0.5
0.6 units on a scale
Standard Deviation 0.8
0.2 units on a scale
Standard Deviation 0.5
0.9 units on a scale
Standard Deviation 0.8
Conjunctival Staining
Inferior
0.6 units on a scale
Standard Deviation 0.7
1.1 units on a scale
Standard Deviation 1.0
0.6 units on a scale
Standard Deviation 0.8
1.2 units on a scale
Standard Deviation 1.2

PRIMARY outcome

Timeframe: Baseline and 8 hours

High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.

Outcome measures

Outcome measures
Measure
Habitual Etafilcon A Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual Etafilcon A Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Habitual FREQ Wearers Randomized to Etafilcon A
n=45 eyes
Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. etafilcon A (control): contact lens
Habitual FREQ Wearers Randomized to Somofilcon A
n=45 eyes
Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design. somofilcon A (test): contact lens
Visual Acuity
Baseline
-0.05 LogMAR
Standard Deviation 0.07
-0.05 LogMAR
Standard Deviation 0.09
-0.07 LogMAR
Standard Deviation 0.06
-0.06 LogMAR
Standard Deviation 0.08
Visual Acuity
8 hours
-0.06 LogMAR
Standard Deviation 0.08
-0.06 LogMAR
Standard Deviation 0.10
-0.07 LogMAR
Standard Deviation 0.08
-0.06 LogMAR
Standard Deviation 0.08

Adverse Events

Etafilcon A Lens (Control) Worn by Habitual Etafilcon A Grp

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Somofilcon A Lens (Test) Worn by Habitual Etafilcon A Grp

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Etafilcon A Lens (Control) Worn by Habitual FREQ Grp

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Somofilcon A Lens (Test) Worn by Habitual FREQ Grp

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Senior Manager Global Medical Scientific Affairs

CooperVision Inc.

Phone: 925 621-3761

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: OTHER